J Am Pharm Assoc (2003). 2019 Jul-Aug;59(4S):S136-S140.e4. doi: 10.1016/j.japh.2019.05.004. Epub 2019 Jun 24.
To develop an electronic tool to aid community-based pharmacists in incorporating diabetes-specific clinical services into pharmacy workflow and to determine the utility of the tool.
Three independent community pharmacy locations.
Realo Discount Drugs is a group of 18 independent community pharmacies, a specialty pharmacy, and a long-term care pharmacy, all with a common owner, serving eastern North Carolina.
An electronic tool was developed to aid pharmacists in identifying gaps in therapy for patients with diabetes in alignment with the 2018 American Diabetes Association Standards of Medical Care in Diabetes. An RX edit (short code) alerted the pharmacist when a diabetes medication was verified. An electronic tool complemented the RX edit, through which the pharmacist would assess the patient record for the presence of an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor blocker (ARB), aspirin, or a statin.
The pharmacist used an electronic tool to identify gaps in therapy, to document medication therapy problems identified, to make therapeutic recommendations to the patient or provider, and to document interventions using the electronic tool.
Pharmacists used the tool 788 times during a 50-day period. Each completion of the tool represented 1 patient profile assessed. Pharmacists identified 99 patients (12.6%) who were not using an ACEI or ARB. Pharmacists recommended ACEI or ARB therapy for 56 patients (56.6%). Pharmacists identified 371 patients (47.1%) who were not using aspirin therapy, and recommended aspirin therapy for 198 patients (53.4%). Pharmacists identified 187 (23.7%) patients who were not given statin therapy and recommended statin therapy for 142 patients (76%). A total of 74 medication therapy problems (18.7%) were resolved.
An electronic tool was developed and integrated into the dispensing workflow. The implementation of an electronic tool helped community-based pharmacists to identify gaps in therapy and to make recommendations in alignment with American Diabetes Association guidelines.
开发一种电子工具，以帮助社区药剂师将糖尿病特定的临床服务纳入药房工作流程，并确定该工具的实用性。
三家独立的社区药房。
Realo Discount Drugs 是由 18 家独立的社区药房、一家专业药房和一家长期护理药房组成的集团，它们都由同一个老板拥有，为北卡罗来纳州东部提供服务。
开发了一种电子工具，以帮助药剂师根据 2018 年美国糖尿病协会糖尿病医疗标准，确定糖尿病患者治疗中的差距。RX 编辑（短代码）在验证糖尿病药物时会提醒药剂师。电子工具补充了 RX 编辑，药剂师可以通过该工具评估患者记录中是否存在血管紧张素转换酶抑制剂 (ACEI) 或血管紧张素 II 受体阻滞剂 (ARB)、阿司匹林或他汀类药物。
药剂师使用电子工具识别治疗中的差距，记录发现的药物治疗问题，向患者或提供者提出治疗建议，并使用电子工具记录干预措施。
在 50 天的时间内，药剂师使用该工具 788 次。每次完成工具代表评估了 1 个患者档案。药剂师发现有 99 名患者（12.6%）未使用 ACEI 或 ARB。药剂师为 56 名患者（56.6%）推荐 ACEI 或 ARB 治疗。药剂师发现有 371 名患者（47.1%）未接受阿司匹林治疗，并为 198 名患者（53.4%）推荐了阿司匹林治疗。药剂师发现有 187 名患者（23.7%）未接受他汀类药物治疗，并为 142 名患者（76%）推荐了他汀类药物治疗。共解决了 74 个药物治疗问题（18.7%）。
开发了一种电子工具并将其整合到配药工作流程中。电子工具的实施帮助社区药剂师识别治疗中的差距，并根据美国糖尿病协会的指南提出建议。
